CDTX vs GILD: Which Stock is Better?

Side-by-side comparison of Cidara Therapeutics Inc and Gilead Sciences Inc in 2026

Comparison Updated:

CDTX

Cidara Therapeutics Inc

GILD

Gilead Sciences Inc

$129.16

Key Metrics Comparison

MetricCDTXGILDWinner
Market Cap$6.96B$160.15BGILD
P/E RatioN/A17.55GILD
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze CDTX

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CDTX or GILD a better investment?

Comparing CDTX and GILD: Cidara Therapeutics Inc has a market cap of $6.96B while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CDTX and GILD?

CDTX (Cidara Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CDTX or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: CDTX or GILD?

Both CDTX and GILD show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: CDTX or GILD?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: CDTX or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $6.96B for CDTX.

Should I buy CDTX or GILD in 2026?

Both CDTX and GILD have investment merit. CDTX trades at $N/A while GILD trades at $129.16. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CDTX and GILD stock?

Key differences: Market Cap ($6.96B vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy CDTX or GILD in 2026?

The choice between CDTX and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between CDTX and GILD?

CDTX (Cidara Therapeutics Inc) has a market cap of $6.96B, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.

Popular Stock Comparisons